ENDPOINTS

Sofinnova raises €165M for new early-stage biotech fund

European life sciences investor Sofinnova Partners disclosed a €165 million acceleration fund on Tuesday to back early-stage science in Italy, France, United Kingdom and Denmark. The fund, Biovelocita II, is 10 times the size of ...

Mar 18, 2025 - 09:17
 0
Sofinnova raises €165M for new early-stage biotech fund
European life sciences investor Sofinnova Partners disclosed a €165 million acceleration fund on Tuesday to back early-stage science in Italy, France, United Kingdom and Denmark. The fund, Biovelocita II, is 10 times the size of ...
Read More

Tags:

Previous Article

‘Frogs carry the weight of our environment on their tiny shoulders’

Next Article

Countries must bolster climate efforts or risk war, Cop30 chief executive warns

Related Posts

GSK, Amgen and AstraZeneca tout Phase 3 data in inflammatory nasal condition 

GSK, Amgen and AstraZeneca tout Phase 3 data in inflamm...

Mar 3, 2025  0

CytomX, Amgen pass on T cell engager; Molecular Partners ends work with Novartis

CytomX, Amgen pass on T cell engager; Molecular Partner...

Mar 7, 2025  0

Bain buys Mitsubishi Tanabe Pharma in $3.3B bet on Japan

Bain buys Mitsubishi Tanabe Pharma in $3.3B bet on Japan

Feb 9, 2025  0